Table 2.
TMD sequence | Length | Origin | Location in end4 | Location (en−) | Location in wild type |
---|---|---|---|---|---|
KMCLALVIIILLVVIIVPIAVHFSR* | 20 | Snc1p | PM | PM | PM |
KCWLIVFAIIVVVVVVVVVPAVVKTR* | 22 | Sso1p | PM | PM | Vac |
KNITLLTFTIILFVSAAFMFFYLW* | 23 | Nyv1p | Vac | Vac | Vac |
KLTTYGAIIMGVFILFLVLDYVG* | 18 | “Ufe1p” | Vac | Vac | Vac |
KLTTYGAIIMGVFILFLVLVLDYVG* | 20 | “Ufe1p” | Vac | Vac | |
KLTTYGAIIMGVFILFLVLVLVLDYVG* | 22 | “Ufe1p” | Vac | Vac | |
KLTTYGAIIMGVFILFLVLVLVLVLVLDYVG* | 26 | “Ufe1p” | PM | PM | Vac |
KVVVVVVVVVVVVVVVVVVVVVVVVVVHFSR* | 26 | Synthetic | PM | Vac | |
KVFVIIFLVLLMVILLLVVLVHFSR* | 20 | Random 1 | PM | Vac | |
KIVVVLILIFVIIIIMLLLILHFSR* | 20 | Random 2 | PM | Vac | |
KLVLLLLFLLMFLLILLLVILHFSR* | 20 | Random 3 | PM | Vac | |
KVLILIFVLFIIFILVIVLVIIL* | 22 | Random 4 | PM | Vac |
The TMD and following residues were exchanged for those shown. “Ufe1p” refers to lengthened versions of the TMD of Ufe1p, inserted residues being underlined in the sequence. PM, plasma membrane; Vac, vacuole.